+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Neuroblastoma Clinical Trial Pipeline Highlights - 2019

  • ID: 4773923
  • Report
  • March 2019
  • Region: Global
  • Fore Pharma
1 of 2
This report, Neuroblastoma Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Neuroblastoma market. It covers emerging therapies for Neuroblastoma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Neuroblastoma pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Neuroblastoma pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Neuroblastoma pipeline products by the company.

Short-term Launch Highlights:

Find out which Neuroblastoma pipeline products will be launched in the US and Ex-US till 2024.

Summary:
  • Neuroblastoma phase 3 clinical trial pipeline products
  • Neuroblastoma phase 2 clinical trial pipeline products
  • Neuroblastoma phase 1 clinical trial pipeline products
  • Neuroblastoma preclinical research pipeline products
  • Neuroblastoma discovery stage pipeline products
  • Neuroblastoma pipeline products short-term launch highlights

Note: Please allow up to 48 hours for delivery after order is placed.
Please Note: This report will be delivered within 2 business days of ordering.
Note: Product cover images may vary from those shown
2 of 2
1. Neuroblastoma Pipeline by Stages

2. Neuroblastoma Phase 3 Clinical Trial Insights

3. Neuroblastoma Phase 2 Clinical Trial Insights

4. Neuroblastoma Phase 1 Clinical Trial Insights

5. Neuroblastoma Preclinical Research Insights

6. Neuroblastoma Discovery Stage Insights

7. Appendix

8. Research Methodology

List of Tables:
Table 1: Neuroblastoma Phase 3 Clinical Trials, 2019
Table 2: Neuroblastoma Phase 2 Clinical Trials, 2019
Table 3: Neuroblastoma Phase 1 Clinical Trials, 2019
Table 4: Neuroblastoma Preclinical Research, 2019
Table 5: Neuroblastoma Discovery Stage, 2019

List of Figures:
Figure 1:: Neuroblastoma Pipeline Molecules by Clinical Trials Stage, 2019
Figure 2: Neuroblastoma Phase 3 Clinical Trial Highlights, 2019
Figure 3: Neuroblastoma Phase 2 Clinical Trial Highlights, 2019
Figure 4: Neuroblastoma Phase 1 Clinical Trial Highlights, 2019
Figure 5: Neuroblastoma Preclinical Research Highlights, 2019
Figure 6: Neuroblastoma Discovery Stage Highlights, 2019
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll